BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6223693)

  • 1. A 125I-protein A-binding assay detecting antibodies to cell surface antigens. Evidence for the presence of specific antibodies against leukemia-associated antigens in human leukemias.
    Fäldt R; Ankerst J
    Cancer Immunol Immunother; 1983; 15(2):69-77. PubMed ID: 6223693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of antibodies binding to autologous and allogeneic leukemic cells in childhood ALL. Evidence for a common ALL antigen(s).
    Fäldt R; Ankerst J; Garwicz S
    Blut; 1986 Jun; 52(6):337-43. PubMed ID: 2941087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of heteroantisera to human acute leukemia-associated antigens.
    Baker MA; Ramachandar K; Taub RN
    J Clin Invest; 1974 Dec; 54(6):1273-8. PubMed ID: 4140196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myeloblastic leukemia-associated antigens: detection and clinical importance.
    Baker MA; Roncari DA; Taub RN; Mohanakumar T; Falk JA
    Haematol Blood Transfus; 1981; 26():332-7. PubMed ID: 6947935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of a tumor-associated antigen on the surface of human myelogenous leukemia cells.
    Malcolm AJ; Shipman RC; Levy JG
    J Immunol; 1982 Jun; 128(6):2599-603. PubMed ID: 7042842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute lymphoblastic leukemia (ALL) antigens detected with antisera to E rosette-froming and non-E rosette-forming ALL blasts.
    Borella L; Sen L; Casper JT
    J Immunol; 1977 Jan; 118(1):309-15. PubMed ID: 318669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of normal myeloid-associated antigens by acute leukemia cells.
    Dinndorf PA; Andrews RG; Benjamin D; Ridgway D; Wolff L; Bernstein ID
    Blood; 1986 Apr; 67(4):1048-53. PubMed ID: 2937468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of series of monoclonal antibodies against human white cell differentiation antigens and the common ALL antigen in the characterization of leukemia cells.
    Hołowiecki J; Stella-Hołowiecka B; Krawczyk-Kuliś M; Wiechnik E; Japa J; Jarczok K; Rudzka E; Duraj M
    Arch Immunol Ther Exp (Warsz); 1984; 32(1):43-9. PubMed ID: 6433853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. I and i antigens on normal and leukemic leukocytes.
    Moore JO; Logue GL
    Cancer; 1978 Jul; 42(1):140-8. PubMed ID: 276411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of an antigen associated with acute leukemia.
    Mann DL; Rogentine GN; Halterman R; Leventhal B
    Science; 1971 Dec; 174(4014):1136-7. PubMed ID: 5289583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
    Andreasen RB; Olsson L
    J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of antibodies to soluble blast cell antigens in acute leukemia].
    Golodnenkova VN; Bulycheva TI; Danilevich SV
    Vopr Onkol; 1980; 26(9):17-22. PubMed ID: 6932783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardization of monoclonal antibodies for use in autologous bone marrow transplantation for common acute lymphoblastic leukemia.
    Bradstock KF; Favaloro EJ; Kabral A; Kerr A; Prendergast M; Berndt MC; Hughes WG; Zola H; Krishnan R; Haylock D
    Pathology; 1986 Apr; 18(2):197-205. PubMed ID: 2945154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of neuraminidase treatment on serum reactivity to autologous leukemic blast cells.
    Pfreundschuh M; Dörken B; Brandeis W; Hunstein W; Wernet P
    Cancer Immunol Immunother; 1983; 15(3):194-9. PubMed ID: 6193868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of minimal residual disease in acute myeloid leukemia.
    Gerhartz HH; Schmetzer H
    Leukemia; 1990 Jul; 4(7):508-16. PubMed ID: 1695705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficient expression of class-I HLA in some cases of acute leukemia.
    Elkins WL; Pickard A; Pierson GR
    Cancer Immunol Immunother; 1984; 18(2):91-100. PubMed ID: 6239685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance.
    Mirro J; Zipf TF; Pui CH; Kitchingman G; Williams D; Melvin S; Murphy SB; Stass S
    Blood; 1985 Nov; 66(5):1115-23. PubMed ID: 3931724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia diagnosis and testing of complement-fixing antibodies for bone marrow purging in acute lymphoid leukemia.
    Campana D; Janossy G
    Blood; 1986 Dec; 68(6):1264-71. PubMed ID: 3535926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative variation of the common acute lymphoblastic leukemia antigen (gp100) on leukemic marrow blasts.
    Look AT; Melvin SL; Brown LK; Dockter ME; Roberson PK; Murphy SB
    J Clin Invest; 1984 Jun; 73(6):1617-28. PubMed ID: 6233301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.